Health care stocks gained late Friday afternoon, with the NYSE Health Care Index rising 2% and the Health Care Select Sector SPDR Fund (XLV) adding 1.8%.
The iShares Biotechnology ETF (IBB) advanced 0.8%.
In corporate news, Kura Oncology (KURA) shares rose past 11% after a regulatory filing showed CEO Troy Wilson bought 50,000 shares of the company.
UnitedHealth Group (UNH) jumped more than 12% after Berkshire Hathaway (BRK.A, BRK.B) said in a filing that it bought over 5 million shares of the company in Q2.
Medtronic (MDT) is expected to report fiscal Q1 results above market expectations and likely lift its full-year outlook amid easing tariff impacts and forex tailwinds, according to Needham. Medtronic shares added 1%.
Precigen (PGEN) shares surged 59% after the US Food and Drug Administration approved Papzimeos for adults with recurrent respiratory papillomatosis.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.